Skip to content

Verastem

US · VSTM #3468 by market cap
6.33 -0.53 -7.73%
Periodic snapshot; not a real-time feed. · 2026-11-20 19:30

Price chart

Pre-market 6.64 -3.21%
After-hours 6.39 +0.95%
10.103.456.332026-05-262026-11-20
MA5MA10MA20MA60
— MA5 — MA10 — MA20 — MA60
Reader sentiment Are you bullish or bearish on VSTM?

Anonymous reader poll. Unscientific, not investment advice.

✦ StockVane Quant Insights how this is computed

Quant Sentiment Bullish
  • Recent price momentum is -21.3% on average (3-month/1-year).
  • Main-fund capital flow has been a net outflow over the last 45 sessions.
  • Short interest has fallen to 16.2% of float.
  • Analyst tilt is Buy.
Quant Technical Outlook Neutral
  • Price is below its 20-day average and below its 60-day average.
  • The 20-day average is above the 60-day average, a short-term uptrend.
Quant Rating, last 30 days C → D

Computed by a StockVane algorithm from historical price, valuation and analyst data - not a person, not a forecast guarantee, and not investment advice.

Factor grades

Ranked against 2848 U.S. stocks StockVane covers.

Last computed: 2026-11-21 20:27 UTC

Data coverage: 4 of 6 factors. Missing data is not a zero score.

Overall C

The radar needs all six factors. Available grades are shown below.

Valuation N/A

How expensive the stock is versus earnings, sales and its own 5-year history.

Not enough data to grade this factor.

Growth N/A

How fast revenue, profit and free cash flow are compounding.

Not enough data to grade this factor.

Profitability D

How much profit the business keeps from each dollar of sales and capital.

Gross margin 82.9% Better than 92%
Operating margin -550.3% Better than 4%
Net margin -677.6% Better than 3%
Return on equity -1,480.2% Better than 0%
Return on invested capital -269.3% Better than 0%
Momentum B-

Recent price strength, skipping the latest month to avoid short-term noise.

3-month return -8.1% Better than 55%
6-month return 49.3% Better than 95%
12-month return (ex latest month) 0.6% Better than 34%
Distance below 52-week high 41.5% Better than 27%
Financial Health C-

Balance-sheet strength: leverage, liquidity and interest coverage.

Current ratio 3.1x Better than 74%
Debt to assets 35.4% Better than 33%
Interest coverage -183.1x Better than 4%
Analyst View A+

What the Street thinks: share of Buy ratings and upside to the average target.

Analysts rating Buy 100.0% Better than 77%
Upside to average target 192.3% Better than 94%

Grades are relative rankings, not forecasts: A+ is the top 5% of the covered stocks on a factor, F the bottom 3%. Valuation is not adjusted for sector. Background recomputation is scheduled every 6 hours; actual computation time is shown above, and source datasets have different reporting dates. Not investment advice or tailored to your financial situation.

Performance

1W -22.62%
1M -32.23%
3M -7.18%
6M +53.27%
YTD -18.01%
1Y -35.47%
3Y -1.86%
5Y -82.18%

Key statistics

Price & volume

Prev close
6.86
Open
6.63
Day range
6.25 - 6.82
Avg price
6.47
Volume
3.25M
Turnover
21.02M
Amplitude
8.24%
52-week range
3.43 - 10.82

Valuation

P/E
-2.10
P/E (TTM)
-3.44
P/B
79.13
EPS
-3.02
Net profit
-380.56M
Net assets
10.08M

Share structure

Market cap
797.67M
Float cap
750.95M
Shares out
126.01M
Float shares
118.63M

Dividend & listing

Dividend (TTM)
0.00
Listing date
--
52-week range 39% of range
3.43 10.82

41.5% below the 52-week high

Trading activity

Net capital flow main funds, last 45 sessions

-9.60M net over the window

Short interest

Shares short
19.67M
As of
2026-10-30

Frequently asked questions

What is the current stock price of Verastem (VSTM)?

Verastem last traded at 6.33. This page shows a periodic quote snapshot. Check the displayed quote time.

What is Verastem's market cap?

About 797.67M.

What is the P/E ratio of Verastem?

The trailing twelve-month P/E is -3.44, below its own 5-year average of 10.89 — toward the bottom of its historical range (0.56% percentile). See the Valuation tab for the full history.

Does Verastem pay a dividend?

Verastem does not currently pay a regular dividend.

Is Verastem a buy according to analysts?

The consensus of 7 analysts is a Buy rating, with an average 12-month price target of 18.50, which implies 192.3% upside from the current price. This is not investment advice.

What is Verastem's StockVane Quant Rating?

The StockVane Momentum strategy currently rates Verastem a D (Sell). Below its 200-day average or in the bottom third on momentum — the strategy is out of it. Not investment advice.

Quote time 2026-11-20 19:30:05 · For reference only, not investment advice and not tailored to your situation.

Verastem discussion 0 comments

Add a comment